Premorbid BMI as a prognostic factor in small-cell lung cancer—a single institute experience

作者：Cho‐Hao Lee, Chin Lin, Chieh‐Yung Wang, Tzu‐Chuan Huang, Yi‐Ying Wu, Wu‐Chien Chien, Jia-Hong Chen · 发表于：Oncotarget · 年份：2018 · DOI：10.18632/oncotarget.24935 · 被引用次数：18 · 研究领域：Neuroendocrine Tumor Research Advances、Congenital Diaphragmatic Hernia Studies、Pancreatic and Hepatic Oncology Research

// Cho-Hao Lee 1 , Chin Lin 2, 3 , Chieh-Yung Wang 4 , Tzu-Chuan Huang 1 , Yi-Ying Wu 1 , Wu-Chien Chien 2 and Jia-Hong Chen 1, 5 1 Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China 2 School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China 3 Department of Research and Development, National Defense Medical Center, Taipei, Taiwan, Republic of China 4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China 5 Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, Republic of China Correspondence to: Jia-Hong Chen, email: ndmc_tw.tw@yahoo.com.tw Keywords: overweight; small-cell lung cancer; prognostic factor; body mass index Received: September 29, 2017      Accepted: March 05, 2018      Published: May 15, 2018 ABSTRACT Numerous evidence has indicated that excess weight is associated with an increased risk of mortality in patients in several cancer types including breast, colorectal, pancreatic, endometrial, and prostate cancer However, with respect to non-small cell lung cancer and upper aero-digestive cancer, evidence suggests that low body mass index (BMI) may increase the risk of mortality of these...